FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2915742562> ?p ?o ?g. }

• W2915742562 endingPage "253" @default.
• W2915742562 startingPage "245" @default.
• W2915742562 abstract "Maintaining the optimum bone health is one of the important concerns in patients with prostate cancer, but it usually remains neglected. Failure to screen these patients is detrimental to both the length and the quality of life. The estimation of bone mineral density (BMD) and more recently the World Health Organization's fracture risk assessment (FRAX) algorithm in appropriate patients is recommended by several specialty organizations/associations at the time of instituting androgen deprivation therapy (ADT) for metastatic and high-risk individuals. It provides a 10-year risk evaluation of hip and major osteoporotic fractures (MOF). Using this web-based new investigating tool, candidates at high risk of fractures can be predicted more accurately according to clinical risk factors (CRF) alone or in combination with the femoral neck BMD. The FRAX application for senile osteoporosis has been studied and reviewed extensively, but no systematic review has ever been conducted for assessing the implication of FRAX in prostate cancer. This review article will give insight about the validity, role, and utility of this investigating tool in clinical practice for fracture risk assessment in these individuals.This systematic review was carried out as per the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines and Cochrane review principles. We searched the PubMed, Cochrane database of systematic reviews, and the EMBASE electronic database until December 2018 using the medical subject heading terms prostate cancer and FRAX.A total of nine studies meet the inclusion criteria and were included in the review. These studies enrolled a total of 3704 patients (sample size range, 78-1220) of localized, metastatic, castration resistant prostate cancer with or without ADT and/or on photon or radiotherapy. The factors that influenced FRAX included age, ethnicity, baseline BMD, duration of ADT, presence of CRF, and measurement methods (CRF, with/without BMD, computed tomography based). An advanced age and duration of ADT were the most robust risk factors. A 10-year MOF and hip fracture risk estimation was higher when the femoral neck BMD was not incorporated in the FRAX measurement. Despite several well-known strengths of using FRAX in the fracture risk assessment of suitable candidates with prostate cancer, several risk factors such as the mode/duration of ADT, mode of radiotherapy, Vitamin D levels, bone remodeling markers, and recent/recurrent fractures need to be incorporated in the FRAX calculator for improving the predictive ability. In contrast to senile osteoporosis with a longer life expectancy, the fracture risk in patients with prostate cancer need to be measured more frequently and for a shorter time. Therefore, models like Garvan calculator with both 5- and 10-year risk estimates have to be developed for these patients. Additionally, its utilization is of limited value in the presence of recurrent fractures or falls.The FRAX algorithm is beneficial in identifying patients who require early intervention or bone-directed therapy as an early step to decrease skeletal-related events and other morbidity. Several risk factors need to be added for improving the FRAX predictive value. This model is still underutilized in the clinical practice and increasing the awareness among treating physicians will help in optimizing the bone health and the quality of life of this important population subgroup." @default.
• W2915742562 created "2019-03-02" @default.
• W2915742562 creator A5013708354 @default.
• W2915742562 creator A5017608012 @default.
• W2915742562 creator A5036347283 @default.
• W2915742562 creator A5058935905 @default.
• W2915742562 creator A5067446295 @default.
• W2915742562 creator A5090385202 @default.
• W2915742562 date "2019-07-08" @default.
• W2915742562 modified "2023-10-03" @default.
• W2915742562 title "Implications of the Fracture Risk Assessment Algorithm for the assessment and improvement of bone health in patients with prostate cancer: A comprehensive review" @default.
• W2915742562 cites W1513287091 @default.
• W2915742562 cites W1910164612 @default.
• W2915742562 cites W1968838737 @default.
• W2915742562 cites W1970352575 @default.
• W2915742562 cites W1997732940 @default.
• W2915742562 cites W1999752200 @default.
• W2915742562 cites W2017916933 @default.
• W2915742562 cites W2020830322 @default.
• W2915742562 cites W2022091463 @default.
• W2915742562 cites W2024266959 @default.
• W2915742562 cites W2029332257 @default.
• W2915742562 cites W2035877913 @default.
• W2915742562 cites W2043150075 @default.
• W2915742562 cites W2046834809 @default.
• W2915742562 cites W2053662837 @default.
• W2915742562 cites W2063107357 @default.
• W2915742562 cites W2067337981 @default.
• W2915742562 cites W2072987335 @default.
• W2915742562 cites W2073414116 @default.
• W2915742562 cites W2083492047 @default.
• W2915742562 cites W2100944117 @default.
• W2915742562 cites W2117460748 @default.
• W2915742562 cites W2122906075 @default.
• W2915742562 cites W2128173189 @default.
• W2915742562 cites W2133911598 @default.
• W2915742562 cites W2146125007 @default.
• W2915742562 cites W2151807391 @default.
• W2915742562 cites W2156098321 @default.
• W2915742562 cites W2397848956 @default.
• W2915742562 cites W2433609165 @default.
• W2915742562 cites W246286872 @default.
• W2915742562 cites W2498788895 @default.
• W2915742562 cites W2511755939 @default.
• W2915742562 cites W2592723445 @default.
• W2915742562 cites W2607028219 @default.
• W2915742562 cites W2895220093 @default.
• W2915742562 cites W3034058096 @default.
• W2915742562 cites W4205145397 @default.
• W2915742562 cites W2236090822 @default.
• W2915742562 doi "https://doi.org/10.5152/tud.2019.11736" @default.
• W2915742562 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6619849" @default.
• W2915742562 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30817274" @default.
• W2915742562 hasPublicationYear "2019" @default.
• W2915742562 type Work @default.
• W2915742562 sameAs 2915742562 @default.
• W2915742562 citedByCount "9" @default.
• W2915742562 countsByYear W29157425622020 @default.
• W2915742562 countsByYear W29157425622021 @default.
• W2915742562 countsByYear W29157425622022 @default.
• W2915742562 countsByYear W29157425622023 @default.
• W2915742562 crossrefType "journal-article" @default.
• W2915742562 hasAuthorship W2915742562A5013708354 @default.
• W2915742562 hasAuthorship W2915742562A5017608012 @default.
• W2915742562 hasAuthorship W2915742562A5036347283 @default.
• W2915742562 hasAuthorship W2915742562A5058935905 @default.
• W2915742562 hasAuthorship W2915742562A5067446295 @default.
• W2915742562 hasAuthorship W2915742562A5090385202 @default.
• W2915742562 hasBestOaLocation W29157425622 @default.
• W2915742562 hasConcept C121608353 @default.
• W2915742562 hasConcept C12174686 @default.
• W2915742562 hasConcept C126322002 @default.
• W2915742562 hasConcept C150241267 @default.
• W2915742562 hasConcept C17744445 @default.
• W2915742562 hasConcept C1862650 @default.
• W2915742562 hasConcept C189708586 @default.
• W2915742562 hasConcept C199539241 @default.
• W2915742562 hasConcept C2775854910 @default.
• W2915742562 hasConcept C2776478404 @default.
• W2915742562 hasConcept C2776541429 @default.
• W2915742562 hasConcept C2776886416 @default.
• W2915742562 hasConcept C2777525943 @default.
• W2915742562 hasConcept C2777899217 @default.
• W2915742562 hasConcept C2778885795 @default.
• W2915742562 hasConcept C2779473830 @default.
• W2915742562 hasConcept C2780192828 @default.
• W2915742562 hasConcept C2994343686 @default.
• W2915742562 hasConcept C38652104 @default.
• W2915742562 hasConcept C41008148 @default.
• W2915742562 hasConcept C71924100 @default.
• W2915742562 hasConcept C95190672 @default.
• W2915742562 hasConceptScore W2915742562C121608353 @default.
• W2915742562 hasConceptScore W2915742562C12174686 @default.
• W2915742562 hasConceptScore W2915742562C126322002 @default.
• W2915742562 hasConceptScore W2915742562C150241267 @default.
• W2915742562 hasConceptScore W2915742562C17744445 @default.
• W2915742562 hasConceptScore W2915742562C1862650 @default.
• W2915742562 hasConceptScore W2915742562C189708586 @default.

• next